Stocktoria
Aspire Biopharma Holdings, Inc. ASBP
Aspire Biopharma Holdings, Inc. statistics & valuation
Market cap$7.8M
Net margin-394725.1%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | -1.9% | — | — | — |
| Operating margin | -312016.9% | — | — | — |
| Net margin | -394725.1% | — | — | — |
| Return on assets | -1865.7% | -885.1% | 22.3% | 1.1% |
| Return on equity | 383.9% | 85.1% | -915.0% | -33.6% |
| Current ratio | 0.17 | 0.09 | 0.20 | 3.62 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.